Filing Details

Accession Number:
0001104659-19-012066
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-01 17:00:53
Reporting Period:
2019-02-28
Accepted Time:
2019-03-01 17:00:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1330436 Liquidia Technologies Inc LQDA Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1747047 Benjamin Maynor 419 Davis Drive, Suite 100
Morrisville NC 27560
Svp, Research And Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-28 2,187 $1.85 6,355 No 4 M Direct
Common Stock Disposition 2019-02-28 50 $18.95 6,305 No 4 S Direct
Common Stock Disposition 2019-02-28 2,137 $19.86 4,168 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2019-02-28 2,187 $0.00 2,187 $1.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,132 2011-05-12 2020-11-23 No 4 M Direct
Footnotes
  1. The partial option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2018.
  2. The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.52 to $20.04, inclusive. The reporting person undertakes to provide to Liquidia Technologies, Inc., any holder of Liquidia Technologies, Inc. stock or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4.